|
answer text |
<p> </p><p>The following table shows expenditure on research on motor neurone disease
(MND) and amyotrophic lateral sclerosis (ALS - a sub type of MND) by the Medical Research
Council and by the National Institute for Health Research (NIHR) through its research
programmes, research centres and units, and research fellowships.</p><p> </p><p>£
million</p><p><em> </em></p><table><tbody><tr><td><p> </p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td><p>Medical
Research Council</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>n/a</p></td></tr><tr><td><p>National
Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.6</p></td><td><p>4.6</p></td><td><p>4.8</p></td><td><p>n/a</p></td></tr></tbody></table><p>
</p><p>Total spend by the NIHR on MND/ALS is higher than this because expenditure
by the NIHR Clinical Research Network (CRN) on this topic cannot be disaggregated
from total CRN expenditure.</p>
|
|